All News #Library
Rare Diseases
Modalis Receives Orphan Drug Designation for MDL-101 in CMD
25 Oct 2024 //
BUSINESSWIRE
Modalis FDA Grants Pediatric Disease Designation To MDL-101 for DMD
30 Sep 2024 //
BUSINESSWIRE

Market Place
Sourcing Support